Physician Practice Billing Incentives: What the Code Pays and Who Gets the Money

Physician practice billing incentives can drive fraud when a business rewards higher codes, more services or more referrals and pressures staff to produce claims the care cannot support. A coder sees the level change. A physician sees the productivity target. Someone in finance sees the bonus formula. Connecting those views explains how a decision inside the practice becomes a bill to Medicare.

The money can arrive as a professional fee, a laboratory payment, drug reimbursement or a share of a health plan’s revenue. Each rewards something different, and each has its own recipient. Physician upcoding changes the service represented on a claim. The payment and compensation formulas explain who benefits from that change.

What Does Medicare Pay for in an RVU?

Medicare’s physician fee schedule pays for physician work, practice expense and malpractice expense. A higher code can raise both the billed payment and the work credited toward a physician’s productivity bonus. The fee schedule assigns relative value units to the three components, adjusts each for geography, adds them together and applies a dollar conversion factor. The work RVU is only one part of that calculation.

The Centers for Medicare & Medicaid Services’ payment explanation distinguishes work from practice expense and malpractice expense. A physician’s employment contract may pay a negotiated amount per work RVU. That contract rate and Medicare’s conversion factor price different things: one sets compensation for credited work, while the other helps price the whole covered service.

For ordinary Medicare physician services, the program generally pays 80% of the allowed charge after the deductible. The patient’s responsibility and the practice’s actual collections remain separate. A productivity report, an allowed-charge report and a bank deposit therefore answer different questions about the same day’s work.

How Do Doctors Get Paid If They Own Their Own Practice?

Doctors who own a practice can receive compensation through salary, productivity pay, bonuses and the practice’s financial performance. Practice revenue pays for the business as well as its physicians. Staff, space, equipment and drug purchases sit between receipts and the money an owner takes home.

The American Medical Association’s March 2026 compensation report, using its 2024 survey, found that 60.8% of physicians received compensation through more than one method. Owners and employees both received productivity-based compensation. A salary can sit alongside a bonus that changes with billed work, so the base salary alone tells only part of the story.

For a whistleblower, the useful detail is what the formula rewards. A bonus based on personally performed work follows a different money path from a bonus based on laboratory referrals or hospital revenue generated by those referrals. The compensation terms and referral targets connect the practice’s receipts to an individual’s incentive. A large laboratory receipt or expensive drug claim is practice revenue before it is anyone’s personal pay.

Fee-for-Service and Risk Contracts Reward Different Things

Fee-for-service payment rewards paid services: more encounters, more services within an encounter or a different code mix can increase receipts. Capitated arrangements put payment against a covered period or patient population. The contract determines which organization receives that payment and what care it must provide in return.

Medicare Advantage diagnosis coding can change a health plan’s risk-adjusted revenue without changing the office visit’s CPT allowance. The practice participates in those economics through its fee, capitation or risk-sharing contract. The diagnosis, the submission to the plan and the downstream payment belong together when we examine who stood to gain.

Seoul Medical Group illustrates that connection. The Justice Department’s settlement announcement described allegations that false diagnoses increased Medicare Advantage payments, a portion of which reached the group. Its whistleblower’s complaint alleged that unsupported diagnoses inflated risk scores without corresponding treatment and that the group failed to withdraw false codes or return resulting overpayments. The alleged incentive reached beyond the visit fee.

Ancillary Revenue Extends Beyond the Physician’s Work

Imaging and laboratory services can generate revenue beyond the office visit that led to the order. For imaging claims, the professional component pays for interpretation and a written report, while the technical component recognizes the resources used to perform the test. Global billing covers both components when the biller is entitled to both. Most routine clinical laboratory tests use a separate laboratory fee schedule.

The setting also changes the payment. An office generally uses Medicare’s nonfacility physician rate, which recognizes office resources. In a hospital setting, the professional claim uses the facility rate and the hospital may submit its own institutional claim. The physician fee alone does not show the price of that encounter, and the hospital’s receipt does not show the physician’s pay.

A Robert Wood Johnson Foundation research synthesis published in 2008 identified a particular attraction of ancillary ownership: earnings could grow without a matching increase in the physician’s time. Its explanation is still useful for understanding the payment path:

That is why the destination of an order matters to the economics. Someone reading only the physician’s work-RVU report can miss the revenue generated by the referred test. The financial relationship behind the ancillary order connects the clinical decision to the business receiving that revenue, the issue behind the Stark Law allegations in the next case.

Northwest Anesthesiology and Pain Services reported approximately $1.8 million in bonus payments during 2019 through 2021 and agreed to a $999,999 settlement. According to the Justice Department’s announcement, the bonuses allegedly followed laboratory referrals less costs and fees, rather than the contractual practice-productivity measure. The settlement was smaller than the reported bonuses. We see the incentive in that alleged formula: pay for the laboratory business generated by the orders, not the physician’s work.

Buy-and-Bill Revenue Starts With a Drug Purchase

In buy-and-bill, a practice acquires a drug, holds it in inventory, administers it and bills for the covered drug and administration service. Inflated drug units or infusion time can turn that transaction into an overpayment. Medicare’s general Part B drug formula uses average sales price plus 6%. Average sales price is a manufacturer-reported measure, while the practice pays its own acquisition price and bears its own costs.

The Medicare drug-payment manual prices drug billing units, with payment limits that can change by quarter. Discounts, vial sizes, discarded quantities, collections and operating costs affect what the practice retains. The practice’s margin comes from what it actually bought, furnished, billed and collected.

The Centers for Medicare & Medicaid Services’ discarded-drug guidance distinguishes eligible discarded amounts from zero waste through the JW and JZ modifiers. A claim for drug units beyond what was administered or eligible for discarded-drug payment creates a different discrepancy from an inflated infusion duration. The records can show whether the bill reflects the vial actually used, the dose given and the amount discarded. No-cost deliveries also belong in the inventory account. We connect the stock on hand to the units claimed, then examine the payment rules for that stock.

When the Payment Formula Becomes a Billing Instruction

An incentive becomes visible in the instructions that turn work into claims. In the government’s complaint against IPC The Hospitalist Company, hospitalists allegedly received 70% of monthly billings remaining after salary and benefit costs. The complaint described the pressure that accompanied that formula:

IPC allegedly ranked hospitalists against one another and discussed individual billing performance in meetings. TeamHealth, IPC’s successor, agreed to a $60 million settlement of the upcoding allegations. The government alleged that management supplied the pressure to raise billings. We see the absurdity in that alleged incentive: a pricier description of the visit earned a bigger bonus. Same care, better payday.

The Sparrow whistleblower’s complaint described work-RVU benchmarks for incentive pay alongside a push for higher service codes under an efficiency initiative. The allegation puts the productivity target beside the coding instruction. That pairing explains more about pressure inside a practice than either a compensation survey or a high-code report alone.

The service date remains essential when examining false billing. Since January 2021, office evaluation and management levels have depended on medical decision making or the reporting practitioner’s qualifying total time on the service date. A longer history or examination does not select the level. The Centers for Medicare & Medicaid Services’ office-visit guidance supplies the rule behind that comparison.

Software can supply the claimed service before the physician signs. The Justice Department’s complaint alleged that Vohra Wound Physicians used a system that selected surgical debridement codes, generated supporting language and added modifier 25 for an additional visit without the necessary separate service. Vohra and its owner settled those allegations in November 2025. The alleged mechanism connected software settings and training to the transmitted bill.

Productivity figures can also credit a physician with work someone else performed. The practitioner named on the claim matters when a practice bills under a physician’s identity for services that lack the required physician involvement or supervision. The staff schedule and the submitted claim can show whose work generated the payment.

Referral Payments Can Sit Outside the Paycheck

The government’s complaint against Community Health Network alleged that a portion of incentive compensation depended on meeting revenue targets generated by physician referrals to the hospital. It also described an emphasis on downstream imaging revenue. Those allegations connect the physician’s compensation to services that other parts of the organization billed, rather than just the physician’s own work.

An acquisition can carry a similar incentive. The Justice Department alleged that Oliver Street Dermatology Management increased purchase prices for acquired practices in exchange for later referrals to affiliated providers that submitted Medicare claims. The alleged exchange raised Anti-Kickback Statute and Stark Law concerns: the payment sat in the purchase price, before the later referral revenue arrived. Management and acquisition arrangements can explain who set the terms that shaped the subsequent claims.

The Records Connect the Incentive to Government Money

A compensation plan explains what earns a bonus, while a coding instruction explains what staff were expected to submit. The clinical and billing records show whether the patient received the represented service. Schedules, practitioner identities, referral records, inventory and remittances connect the instruction to the work and the payment.

Claims comparisons can identify a pattern worth examining. Chart review supplies the patient-level detail, and internal warnings or management responses can show who understood the discrepancy. In these cases, the insider’s contribution is the connection between the financial target and what the company asked people to do to reach it.

A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers. If your healthcare role gives you that view of the claims and the payment formula, talk to us about the decisions behind them. We connect the people setting the target, changing the system and receiving the money across the health care business.

You Know What the Bonus Was Buying

If you know how a coding target, referral formula or drug-billing instruction changed the claims your practice sent, speak with our whistleblower experts about the money behind those claims. We work beside you to build the case around the decisions you saw and bring in physician-practice fraud whistleblower lawyers who understand compensation and reimbursement. You bring the inside view of the business; we bring the expertise and partnership to pursue it with you.